Refractive Surgery News

The question needs to be qualified a little bit to explain why we are doing the IOL exchange in the first place.

IOL exchange remains an important surgical procedure for the consultative ophthalmologist.

As presbyopia-correcting drops from different companies go through clinical trials and receive U.S. marketing approval, there is excitement about what these drops could mean for middle-aged presbyopes who dislike reading glasses.

With modern calculations and state-of-the-art lenses, IOL exchange is not regularly needed.

In this Healio Video Perspective, Cathleen McCabe, MD, discusses the phase 3 results of Vuity eye drops (pilocarpine HCl ophthalmic solution 1.25%, Allergan) for presbyopia.

NEW ORLEANS — Artificial intelligence may be used as a refractive surgery diagnostic tool, according to a speaker at Refractive Surgery Subspecialty Day at the American Academy of Ophthalmology meeting.

LensGen has received approval for an investigational device exemption from the FDA, paving the way for a pivotal study of the Juvene IOL, according to a company press release.

NEW ORLEANS — Dan Z. Reinstein, MD, offered pearls for therapeutic custom ablation at Refractive Surgery Subspecialty Day at the American Academy of Ophthalmology meeting.

NEW ORLEANS — The $210 billion spent annually on global vision correction suggests potential growth for refractive surgery, according to a speaker.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Rajesh K. Rajpal, MD, chief medical officer and global head of clinical and medical affairs at Johnson & Johnson Vision, offers insights on myopia.